Intuitive Surgical analyst raises eyebrows with new stock price target
This is what could happen next to Intuitive Surgical shares.
Jim Cramer wants answers.
The CNBC anchor and Mad Money maven wants to know why Deutsche Bank was being so rough on Intuitive Surgical (ISRG) .
The investment firm downgraded the biotech to sell from hold and slashed its stock price target to $440 from $515.
